Evidence map›Paper›PMID 25977816›Full record

ArticleScientific data2015

Sequence variants from whole genome sequencing a large group of Icelanders.

Daniel F Gudbjartsson, Patrick Sulem, Hannes Helgason, Arnaldur Gylfason, Sigurjon A Gudjonsson, Florian Zink, Asmundur Oddson, Gisli Magnusson, Bjarni V Halldorsson, Eirikur Hjartarson and 7 more

Abstract readDataset
In one paragraph

Article in Scientific data, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 42 papers, 8 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
42citing papers in PubMed, 8 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

42 citing papers in PubMed, 8 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Pooled it
  7. Pooled it
  8. Pooled it
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors.

Daniel F GudbjartssondeCODE genetics/Amgen, Inc. , Reykjavik 101, Iceland ; School of Engineering and Natural Sciences, University of Iceland , Reykjavik 101, Iceland.
Patrick SulemdeCODE genetics/Amgen, Inc. , Reykjavik 101, Iceland.
Hannes HelgasondeCODE genetics/Amgen, Inc. , Reykjavik 101, Iceland ; School of Engineering and Natural Sciences, University of Iceland , Reykjavik 101, Iceland.
Arnaldur GylfasondeCODE genetics/Amgen, Inc. , Reykjavik 101, Iceland.
Sigurjon A GudjonssondeCODE genetics/Amgen, Inc. , Reykjavik 101, Iceland.
Florian ZinkdeCODE genetics/Amgen, Inc. , Reykjavik 101, Iceland.
Asmundur OddsondeCODE genetics/Amgen, Inc. , Reykjavik 101, Iceland.
Gisli MagnussondeCODE genetics/Amgen, Inc. , Reykjavik 101, Iceland.
Bjarni V HalldorssondeCODE genetics/Amgen, Inc. , Reykjavik 101, Iceland ; Institute of Biomedical and Neural Engineering, Reykjavík University , Reykjavík 101, Iceland.
Eirikur HjartarsondeCODE genetics/Amgen, Inc. , Reykjavik 101, Iceland.
Gunnar Th SigurdssondeCODE genetics/Amgen, Inc. , Reykjavik 101, Iceland.
Augustine KongdeCODE genetics/Amgen, Inc. , Reykjavik 101, Iceland ; School of Engineering and Natural Sciences, University of Iceland , Reykjavik 101, Iceland.
Agnar HelgasondeCODE genetics/Amgen, Inc. , Reykjavik 101, Iceland ; Department of Anthropology, University of Iceland , Reykjavik 101, Iceland.
Gisli MassondeCODE genetics/Amgen, Inc. , Reykjavik 101, Iceland.
Olafur Th MagnussondeCODE genetics/Amgen, Inc. , Reykjavik 101, Iceland.
Unnur ThorsteinsdottirdeCODE genetics/Amgen, Inc. , Reykjavik 101, Iceland ; Faculty of Medicine, University of Iceland , Reykjavik 101, Iceland.
Kari StefanssondeCODE genetics/Amgen, Inc. , Reykjavik 101, Iceland ; Faculty of Medicine, University of Iceland , Reykjavik 101, Iceland.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

We have accumulated considerable data on the genetic makeup of the Icelandic population by sequencing the whole genomes of 2,636 Icelanders to depth of at least 10X and by chip genotyping 101,584 more. The sequencing was done with Illumina technology. The median sequencing depth was 20X and 909 individuals were sequenced to a depth of at least 30X. We found 20 million single nucleotide polymorphisms (SNPs) and 1.5 million insertions/deletions (indels) that passed stringent quality control. Almost all the common SNPs (derived allele frequency (DAF) over 2%) that we identified in Iceland have been observed by either dbSNP (build 137) or the Exome Sequencing Project (ESP) while only 60 and 20% of rare (DAF<0.5%) SNPs and indels in coding regions, the most heavily studied parts of the genome, have been observed in the public databases. Features of our variant data, such as the transition/transversion ratio and the length distribution of indels, are similar to published reports.

Indexed as

Genome, HumanSequence Analysis, DNABase SequenceGene FrequencyHigh-Throughput Nucleotide SequencingHumansIcelandINDEL MutationPolymorphism, Single Nucleotide

Identifiers

PMID25977816
PMCPMC4413226

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.